Visual Processing during Short-Term Memory Binding in Mild Alzheimer’s Disease

FERNÁNDEZ, GERARDO; OROZCO, DAVID; AGAMENNONI, OSVALDO; SCHUMACHER, MARCELA; SAÑUDO, SILVANA; BIONDI, JUAN; PARRA, MARIO A.

JOURNAL OF ALZHEIMER'S DISEASE

IOS PRESS

Año: 2018 p. 1 - 10

1387-2877

Patients with Alzheimer disease (AD) typically present with attentional and oculomotor abnormalities that can have an impact on visual processing and associated cognitive functions. Over the last few years we have witnessed a shift towards the analyses of eye movement behaviors as a means to further our understanding of the pathophysiology of common disorders such as AD. However, little work has been done to unveil the link between eye moment abnormalities and poor performance on cognitive tasks known to be markers for AD patients, such as the short-term memory-binding task. This was the aim of the present study. We analyzed eye movement fixation behaviors of thirteen healthy older adults (Controls) and thirteen patients with probable mild AD while they performed the visual short-term memory binding task (Parra et al., 2011). The short-term memory binding task asks participants to detect changes across two consecutive arrays of two bicolored object who features (i.e., colors) had to be remembered separately (i.e., Unbound Colors), or combined within integrated objects (i.e., Bound Colors). Patients with mild AD showed the well-known pattern of selective memory binding impairments. This was accompanied by significant impairments in their eye movements only when they processed Bound Colors. Patients with mild AD remarkably decreased their mean gaze duration during the encoding time when processing color-color bindings. These findings open new windows of research into the pathophysiological mechanisms of memory deficits in AD patients and the link between its phenotypic expressions (i.e., oculomotor and cognitive disorders). We discuss these findings considering current trends regarding clinical assessment, neural correlates, and potential avenues for robust biomarkers.